Treatment of Delirium in Older Adults with Quetiapine

Abstract

Delirium is a neuropsychiatric syndrome characterized by impairment of consciousness, changes in cognition, or perceptual disturbances. In addition, delirium is often accompanied by delusions, hallucinations, and agitation. In this study, 12 older patients with delirium were treated for neuropsychiatric symptoms with quetiapine. The mean duration for stabilization was 5.91 ± 2.22 days, and the mean dose was 93.75 ± 23.31 mg/day. None of the 12 patients developed extrapyramidal symptoms. There were significant improvements on all measures used in this study. Interestingly, the Delirium Rating Scale scores along with scores of the Mini-Mental State Examination and Clock Drawing Test continued to improve throughout the 3-month study period. In our study, we found that quetiapine was a safe and effective treatment in hospitalized older patients with delirium. (J Geriatr Psychiatry Neurol 2003; 16:29-31)

Get full access to this article

View all access options for this article.

References

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.

2. Levkoff SE, Evans DA, Lipzin B, et al. Delirium: the occurrence and persistence of symptoms among elderly hospitalized patients. Arch Inter Med 1992; 152: 334-340.

3. Lipowski ZJ. Delirium (acute confusional state). JAMA 1987; 258: 1789-1792.

4. Inouye SK. Delirium in hospitalized elderly patients: recognition, evaluation, and management. CT Med 1993; 57: 309-315.

5. Sandberg O, Gustafson Y, Braennstroem B, Bucht G. Clinical profile of delirium in older patients. JAGS 1999; 47: 1300-1306.

6. Shapiro BA, Warren J, Egol AB, et al. Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Crit Care Med 1995; 23: 1596-1600.

7. Sipahimalani A, Masand PS. Use of risperidone in delirium: case reports. Ann Clin Psychiatry 1997; 9: 105-107.

8. Ravona-Springer R, Dolberg OT, Hirschmann S, Grunhaus L. Delirium in elderly patients treated with risperidone: a report of three cases. J Clin Psychopharmacol 1998; 18: 171-172.

9. Sipahimalani A, Sime RM, Masand PS. Treatment of delirium with risperidone. Int J Geriatric Psychopharmacology 1997; 1: 24-26.

10.

10. Sipahimalani A, Masand PS. Olanzapine in the treatment of delirium. Psychosomatics 1998; 39: 422-430.

11.

11. Goren JL, Levin GM. Quetiapine, an atypical antipsychotic. Pharmacotherapy 1998; 18: 1183-1194.

12.

12. McManus DQ, Arvanitis LA, Kowalcyk BB. Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. J Clin Psychiatry 1999; 60: 292-298.

13.

13. Madhusoodanam S, Brenner R, Alcantra A. Clinical experience with quetiapine in elderly patients with psychotic disorders. J Geriatr Psychiatry Neurol 2000; 13: 28-32.

14.

14. Folstein MF, Folstein SE, McHugh PR. “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.

15.

15. Trzepacz PT, Baker RW, Greenhouse J. A rating scale for delirium. Psychiatry Res 1988; 23: 89-97.

16.

16. Wolf-Klein GP, Silverstone FA, Levy AP, et al. Screening for Alzheimer’s disease by clock drawing. J Am Geriatr Soc 1989; 37: 730-734.

17.

17. Guy W. ECDEU assessment manual for psychopharmacology-revised (DHEW Publ No ADM 76-338). Rockville, MD: U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacolgy Research Branch, Division of Extramural Research Program, 1976:218-222.